Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars

Modular Platform for Biosensor Assembly

By R&D Editors | September 23, 2015

UD researchers Wilfred Chen, Qing Sun, and Qi Chen have developed a new biosenor platform to detect cancer. Image: Evan KrapeTumor markers are biological substances, usually proteins, which provide early indication of cancerous or benign tumors in the body.

The markers have a story to tell about what’s going on behind the scenes, but they need help translating it — help that comes from biosensors, which convert biological elements into signals that can be detected and analyzed.

Modern nanofabrication methods have contributed to recent progress in biosensor technology, but challenges remain in developing biosensor assembly platforms that meet important preparation and performance criteria.

Now, a team of researchers from the University of Delaware has developed a new approach that meets at least three of these criteria: system modularity, good signal amplification, and easy purification.

Their work is reported in a paper, “Post-Translational Modification of Bionanoparticles as a Modular Platform for Biosensor Assembly,” in ACS Nano.

Lead author Qing Sun, a doctoral candidate in chemical and biomolecular engineering at UD, explains that their approach involves decorating protein nanoparticles with a wide range of sensing and detection functionalities using a toolbox analogous to a Lego kit.

“The sensor components can be assembled in a variety of ways, which enables us to tailor the search for specific markers,” she says.

“Because the system is modular, we can put any antibody, fluorescence dye, or enzyme on the particles for cancer detection,” she adds. “And every time the target changes, we can change how our sensors are assembled.”

The researchers also report good signal amplification, which means they can get accurate information about the amount of a marker present. This is especially significant during treatment so that clinicians can see whether or not a particular anti-cancer therapy is working.

Finally, purification of bio-nanoparticles for sensing applications has traditionally been time consuming and tedious, but the UD team was able to finish purifying their particles within just an hour under relatively mild conditions.

“Our platform overcomes the disadvantages of many current technologies, and we believe it shows great promise for early cancer detection as well as for monitoring of patients during cancer treatment,” Sun says. “This system is also very flexible so we can expand the modularity, and we can think about using it for other applications like drug delivery.”

The paper was co-authored by Qi Chen, currently a doctoral candidate in chemical and biomolecular engineering; Daniel Blackstock, who completed his doctorate in chemical and biomolecular engineering at UD earlier this year and is now a scientist in the Vaccine Production Program at the National Institutes of Health; and Wilfred Chen, Gore Professor of Chemical Engineering.

Release Date: September 21, 2015
Source: University of Delaware 

Related Articles Read More >

Novel mass spectrometry solution simplifies insight gathering into macromolecular complexes
ENPICOM launches display solution to accelerate antibody selection while maximizing precision
Thermo Fisher Scientific autoimmune-testing instruments now available in the U.S.
Thermo Fisher Scientific and Qatar Genome Program partner to advance precision medicine 
2021 R&D Global Funding Forecast

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2021 Global Funding Forecast

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars